gvtcx

PS24104 - Evaluation of the Medicines and Diagnostics Manufacturing Transformation Fund (MDMTF) and Life Sciences Innovative Manufacturing fund (LSIMF)

DSIT Published 2 Jul 2024 Contracts Finder
The value below is a framework or dynamic market ceiling: the maximum that could be spent across all call-offs, not the value of a single contract. Aggregate figures on this site exclude these to avoid double counting.

key details

Statuscomplete
Category (CPV) 73000000
Deadline28 May 2024
Contract start1 Jul 2024
Contract end30 Jun 2025
Procedureselective
SME suitableYes
OCIDocds-b5fd17-c99c50fb-eb45-4ebc-89ba-f7e46c3ca365

Award

SupplierValueDateStatus
Ipsos (Market Research) Limited £124,955 27 Jun 2024 active

description

***** THIS IS AN AWARD NOTICE, NOT A CALL FOR COMPETITION *****

This procurement is being concluded following a mini competition under the CCS RM6126 Research & Insights DPS

Brief Description of Requirement

A formal evaluation of the processes and impacts of MDMTF and LSIMF is required in order to assess achievements against those expected, identify lessons learned to inform future activity. This will evaluate the initial impact of the projects funded in 2020 and 2022 after an initial 3-year timeline. A light touch process evaluation was conducted in 2021 to assess the programme delivery and early outputs. This resulted in a number of changes to the application process which have been implemented in the delivery of the LSIMF which should also be formally evaluated.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
2 Jul 2024 Award (award) · d73df0fb-b7a7-4364-9575-2f206465341c-763437

more from DSIT

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.